Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Coagulation Disorders | 2 | 2020 | 109 | 1.140 |
Why?
|
| Hemorrhagic Disorders | 4 | 2022 | 22 | 1.130 |
Why?
|
| Menorrhagia | 4 | 2022 | 82 | 1.090 |
Why?
|
| Pathologists | 1 | 2021 | 26 | 0.720 |
Why?
|
| Gastritis | 2 | 2021 | 373 | 0.710 |
Why?
|
| Hematology | 1 | 2020 | 41 | 0.650 |
Why?
|
| von Willebrand Diseases | 4 | 2022 | 54 | 0.640 |
Why?
|
| Factor V Deficiency | 1 | 2019 | 2 | 0.630 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2019 | 5 | 0.630 |
Why?
|
| Nuclear Physics | 6 | 2014 | 17 | 0.630 |
Why?
|
| Fibrinolysis | 1 | 2019 | 44 | 0.620 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 51 | 0.610 |
Why?
|
| Gastric Mucosa | 2 | 2021 | 491 | 0.610 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 271 | 0.600 |
Why?
|
| Tranexamic Acid | 1 | 2019 | 33 | 0.600 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 49 | 0.600 |
Why?
|
| Models, Theoretical | 6 | 2014 | 390 | 0.520 |
Why?
|
| Elementary Particles | 4 | 2014 | 14 | 0.420 |
Why?
|
| Hemorrhage | 3 | 2022 | 519 | 0.280 |
Why?
|
| Blood Preservation | 2 | 2019 | 30 | 0.270 |
Why?
|
| Fatty Liver | 2 | 2025 | 211 | 0.250 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2022 | 419 | 0.240 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 898 | 0.240 |
Why?
|
| von Willebrand Factor | 3 | 2022 | 192 | 0.220 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2024 | 19 | 0.220 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2025 | 85 | 0.220 |
Why?
|
| Parietal Cells, Gastric | 1 | 2024 | 38 | 0.210 |
Why?
|
| Neuroendocrine Tumors | 1 | 2024 | 58 | 0.210 |
Why?
|
| Elementary Particle Interactions | 2 | 2013 | 5 | 0.200 |
Why?
|
| Erythrocytes | 2 | 2019 | 201 | 0.170 |
Why?
|
| Receptors, Estrogen | 1 | 2024 | 728 | 0.170 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2020 | 6 | 0.170 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 12 | 0.170 |
Why?
|
| Cryptosporidiosis | 1 | 2021 | 38 | 0.170 |
Why?
|
| Health Care Surveys | 1 | 2021 | 294 | 0.170 |
Why?
|
| Granulosa Cell Tumor | 1 | 2020 | 38 | 0.170 |
Why?
|
| Point-of-Care Testing | 1 | 2020 | 33 | 0.160 |
Why?
|
| Blood Platelets | 2 | 2019 | 320 | 0.160 |
Why?
|
| Humans | 23 | 2025 | 131985 | 0.160 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2019 | 38 | 0.160 |
Why?
|
| Stem Cells | 1 | 2024 | 732 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 137 | 0.150 |
Why?
|
| Microfluidics | 1 | 2019 | 28 | 0.150 |
Why?
|
| Postpartum Hemorrhage | 1 | 2020 | 111 | 0.150 |
Why?
|
| Diethylnitrosamine | 1 | 2018 | 16 | 0.150 |
Why?
|
| Diagnostic Errors | 2 | 2020 | 347 | 0.150 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2018 | 7 | 0.150 |
Why?
|
| Phenobarbital | 1 | 2018 | 32 | 0.150 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2018 | 59 | 0.150 |
Why?
|
| Thrombelastography | 1 | 2019 | 63 | 0.150 |
Why?
|
| Plasma | 1 | 2019 | 102 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2019 | 130 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 2 | 2019 | 138 | 0.140 |
Why?
|
| Inheritance Patterns | 1 | 2018 | 130 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2018 | 104 | 0.140 |
Why?
|
| Anemia | 1 | 2022 | 350 | 0.140 |
Why?
|
| Liver | 1 | 2025 | 1796 | 0.140 |
Why?
|
| Ovary | 1 | 2020 | 369 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2023 | 721 | 0.140 |
Why?
|
| Esophageal Mucosa | 1 | 2017 | 12 | 0.140 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2017 | 65 | 0.130 |
Why?
|
| Mesons | 2 | 2014 | 7 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1960 | 0.130 |
Why?
|
| Esophagoscopy | 1 | 2017 | 168 | 0.130 |
Why?
|
| Metabolome | 1 | 2019 | 325 | 0.120 |
Why?
|
| Female | 16 | 2025 | 70623 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 363 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 462 | 0.120 |
Why?
|
| Colonic Polyps | 1 | 2017 | 85 | 0.120 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2015 | 36 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 250 | 0.120 |
Why?
|
| Hemolysis | 1 | 2015 | 106 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2022 | 6569 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 3089 | 0.110 |
Why?
|
| Colonoscopy | 1 | 2017 | 252 | 0.110 |
Why?
|
| Precancerous Conditions | 1 | 2017 | 280 | 0.110 |
Why?
|
| Neutrons | 1 | 2014 | 9 | 0.110 |
Why?
|
| Adolescent | 6 | 2025 | 20535 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 262 | 0.110 |
Why?
|
| Barrett Esophagus | 1 | 2017 | 355 | 0.100 |
Why?
|
| Adult | 10 | 2025 | 31547 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 386 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 471 | 0.100 |
Why?
|
| Protons | 1 | 2013 | 98 | 0.100 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 1336 | 0.090 |
Why?
|
| Helicobacter Infections | 1 | 2021 | 1278 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2015 | 526 | 0.090 |
Why?
|
| Middle Aged | 7 | 2025 | 28976 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1015 | 0.080 |
Why?
|
| Healthy Volunteers | 2 | 2019 | 152 | 0.070 |
Why?
|
| Biopsy | 2 | 2025 | 1284 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4683 | 0.070 |
Why?
|
| Child | 3 | 2025 | 25762 | 0.060 |
Why?
|
| Diet | 2 | 2023 | 1125 | 0.060 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2025 | 56 | 0.060 |
Why?
|
| Gastric Acid | 1 | 2024 | 55 | 0.050 |
Why?
|
| Male | 7 | 2025 | 64910 | 0.050 |
Why?
|
| Fast Foods | 1 | 2023 | 23 | 0.050 |
Why?
|
| Bile Duct Neoplasms | 1 | 2024 | 122 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2024 | 357 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2023 | 430 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 3011 | 0.050 |
Why?
|
| Metaplasia | 1 | 2021 | 217 | 0.040 |
Why?
|
| Salpingo-oophorectomy | 1 | 2020 | 10 | 0.040 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.040 |
Why?
|
| von Willebrand Disease, Type 2 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Plasticizers | 1 | 2019 | 3 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 25 | 0.040 |
Why?
|
| Health Behavior | 1 | 2022 | 399 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2018 | 52 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2019 | 98 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 69 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 306 | 0.040 |
Why?
|
| Diarrhea | 1 | 2021 | 330 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2019 | 170 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2020 | 200 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 286 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 824 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2658 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 141 | 0.040 |
Why?
|
| Carcinogens | 1 | 2018 | 127 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2018 | 235 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2019 | 183 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 240 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 6443 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 755 | 0.030 |
Why?
|
| Exome | 1 | 2022 | 1087 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 289 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 304 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2025 | 1102 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 858 | 0.030 |
Why?
|
| Plethysmography | 1 | 2015 | 36 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 61 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2015 | 84 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1181 | 0.030 |
Why?
|
| Vasodilation | 1 | 2015 | 182 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3760 | 0.030 |
Why?
|
| Electrons | 1 | 2014 | 26 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2014 | 145 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1361 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3991 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17391 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2317 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 9952 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3406 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 34789 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5166 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 14732 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 10941 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7543 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 18461 | 0.020 |
Why?
|
| Mutation | 1 | 2020 | 6227 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21415 | 0.020 |
Why?
|